Safety of Dexamethasone in Pregnancy

Introduction to Corticosteroid Use

• The American College of Rheumatology suggests that dexamethasone use in pregnancy carries context-dependent risks and should generally be avoided for maternal indications, but is acceptable for specific fetal indications, with the understanding that fluorinated corticosteroids like dexamethasone readily cross the placenta and pose risks of fetal harm that non-fluorinated alternatives do not 1, 2

Critical Distinction: Fluorinated vs. Non-Fluorinated Corticosteroids

• The key safety consideration is that dexamethasone, a fluorinated corticosteroid, crosses the placenta extensively, while prednisone and prednisolone, non-fluorinated, are largely metabolized before reaching the fetus, as noted by the American College of Rheumatology 3, 2, 4
• Non-fluorinated corticosteroids, such as prednisone and prednisolone, are strongly preferred over dexamethasone or betamethasone for maternal treatment, according to the American College of Rheumatology 1

Approved Fetal Indications for Dexamethasone

• Dexamethasone is acceptable for inducing fetal lung maturity in the context of anticipated preterm birth, as recommended by the American College of Obstetricians and Gynecologists 1
• Dexamethasone 4 mg daily orally is conditionally recommended for pregnant women with anti-Ro/SSA and/or anti-La/SSB antibodies and fetal first- or second-degree heart block, as suggested by the American Heart Association 3, 2, 5, 4

Maternal Safety Concerns

• Risk of exposing both fetus and mother to long-term side effects when used for maternal indications, as warned by the American College of Rheumatology 3, 2
• Potential for irreversible fetal and maternal toxicity with prolonged use, as noted by the American College of Rheumatology 3, 2, 4

Clinical Algorithm for Corticosteroid Selection in Pregnancy

• For maternal disease control, use prednisone or prednisolone as first-line, and avoid dexamethasone and betamethasone for maternal indications, as recommended by the American College of Rheumatology 1
• For fetal indications, dexamethasone is acceptable for lung maturation in preterm birth, and for fetal first- or second-degree heart block with anti-Ro/SSA or anti-La/SSB antibodies, as suggested by the American College of Obstetricians and Gynecologists and the American Heart Association 1, 3, 2, 4

Breastfeeding Considerations

• No specific data available on dexamethasone transfer into human milk, as noted by the American Academy of Pediatrics 6
• Other corticosteroids have been used extensively during breastfeeding with no evidence of adverse effects, as reported by the American Academy of Pediatrics 6

Common Pitfalls to Avoid

• Do not use dexamethasone when prednisone/prednisolone would suffice for maternal treatment, as warned by the American College of Rheumatology 1, 2
• Do not give repeated courses of dexamethasone for fetal lung maturation, as cautioned by the American College of Obstetricians and Gynecologists 1
• Do not continue dexamethasone beyond several weeks for fetal heart block, as advised by the American Heart Association 3, 2
• Do not use dexamethasone for complete (third-degree) heart block, as recommended by the American Heart Association 3, 7, 5, 4

Dexamethasone Use in Pregnancy

Approved Fetal Indications

• High-dose dexamethasone or betamethasone should be given per national guidance to improve fetal lung maturity if delivery is anticipated before 35 weeks' gestation 8
• Dexamethasone can be used as part of prechemotherapy antiemetic regimens during second and third trimesters, but should not be administered after week 35 of pregnancy or within 3 weeks of planned delivery to avoid hematologic complications 9

Dexamethasone Rescue Dose in Pregnancy

Critical Context: Rescue vs. Initial Course

• The American College of Rheumatology recommends 4 mg daily oral dexamethasone for treatment of fetal heart block, as stated by Arthritis and Rheumatology 10, 11

Rescue Course Dosing Algorithm

Important Caveats and Pitfalls

• The European Heart Journal suggests that repeated courses beyond one rescue dose are associated with reduced infant birthweight and head circumference 12

Route of Administration

• The Journal of Clinical Oncology states that intramuscular administration is standard for antenatal corticosteroids for fetal lung maturation, differing from maternal indications where oral or IV routes may be used 13

Avoid Confusion with Other Pregnancy Indications

• The World Journal of Emergency Surgery recommends against using rescue course dosing for postoperative nausea/vomiting, instead suggesting an 8 mg single dose 14
• The European Heart Journal advises against using rescue course dosing for pre-eclampsia acceleration of fetal lung maturity at ≥34 weeks, citing different indication and timing 12
• Arthritis and Rheumatology recommends 4 mg oral dexamethasone daily for fetal heart block, limited duration 10, 11

Safety Profile

Maternal Safety

• The Annals of the Rheumatic Diseases notes that fluorinated corticosteroids (dexamethasone, betamethasone) cross the placenta extensively, which is the intended mechanism for fetal lung maturation, and that risk of maternal hyperglycemia, hypertension, and infection should be monitored 15

Clinical Decision Framework

• The European Heart Journal suggests that if patient received initial course >14 days ago and <34 weeks, assess imminent delivery risk and administer single rescue course if high risk 12